The dysregulation of both ‘classical’ (CB1 and CB2) [13,15,17] and ‘non-classical’ (TRPV1 and GPR55) [21,28] endocannabinoid receptors in EC may provide insights into the variable effects of endocannabinoids observed in different tumour models. This evidence concerns the gene TRPV1 and neoplasm.